Marijuana legalization is one of the most divisive topics of the decade. While proponents swear by its medical abilities and say that taxes from cannabis sales can be used to address various social issues, those against argue that it is a gateway drug and that legalizing it will make it more accessible to children and teenagers. In fact, a survey by Gallup found that 83% of opponents to legalization believe it would make marijuana more accessible to the youth. However, a survey of cannabis use disorders carried out in Colorado and Washington found this to be wholly untrue.
The survey was led by researchers from Temple University and published in the journal Drug and Alcohol Dependence. The study concluded that after recreational marijuana was legalized, “the rate of adolescent treatment admissions for marijuana use declined significantly, with the mean rate falling nearly in half between 2009 and 2017. The decline in admissions rate was greater in Colorado and Washington compared to other states where recreational marijuana is not legal.” This is despite the fact that for more than 70% of minors…
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Do you have questions or are you interested in working with CNW420? Ask our Editor
CNW420 is part of the InvestorBrandNetwork.